DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies

Abstract

Antibodies may bind to bacterial pathogens or their toxins to control infections, and their effector activity is mediated through the recruitment of complement component C1q or the engagement with Fcγ receptors (FcγRs). For bacterial pathogens that rely on a single toxin to cause disease, immunity correlates with toxin neutralization. Most other bacterial pathogens, includingStaphylococcus aureus, secrete numerous toxins and evolved multiple mechanisms to escape opsonization and complement killing. Several vaccine candidates targeting defined surface antigens ofS. aureushave failed to meet clinical endpoints. It is unclear that such failures can be solely attributed to the poor selection of antibody targets. Thus far, studies to delineate antibody-mediated uptake and killing of Gram-positive pathogens remain extremely limited. Here, we exploit 3F6-hIgG1, a human monoclonal antibody that binds and neutralizes the abundant surface-exposed Staphylococcal protein A (SpA). We find that galactosylation of 3F6-hIgG1 that favors C1q recruitment is indispensable for opsonophagocytic killing of staphylococci and for protection against bloodstream infection in animals. However, the simple removal of fucosyl residues, which results in reduced C1q binding and increased engagement with FcγR, maintains the opsonophagocytic killing and protective attributes of the antibody. We confirm these results by engineering 3F6-hIgG1 variants with biased binding toward C1q ormore » FcγRs. While the therapeutic benefit of monoclonal antibodies against infectious disease agents may be debatable, the functional characterization of such antibodies represents a powerful tool for the development of correlates of protection that may guide future vaccine trials.« less

Authors:
ORCiD logo [1];  [1];  [2];  [1]; ORCiD logo [2];  [1]; ORCiD logo [1]
  1. Argonne National Lab. (ANL), Argonne, IL (United States). Howard Taylor Ricketts Lab.; Univ. of Chicago, IL (United States). Dept. of Microbiology
  2. Univ. of Maryland, College Park, MD (United States). Dept. of Chemistry and Biochemistry
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Org.:
USDOE Office of Science (SC)
OSTI Identifier:
1815835
Grant/Contract Number:  
AC02-06CH11357
Resource Type:
Accepted Manuscript
Journal Name:
Proceedings of the National Academy of Sciences of the United States of America
Additional Journal Information:
Journal Volume: 117; Journal Issue: 37; Journal ID: ISSN 0027-8424
Publisher:
National Academy of Sciences
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; monoclonal antibody; glycosylation; C1q; FcγR; Staphylococcal protein A

Citation Formats

Chen, Xinhai, Shi, Miaomiao, Tong, Xin, Kim, Hwan Keun, Wang, Lai-Xi, Schneewind, Olaf, and Missiakas, Dominique. Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies. United States: N. p., 2020. Web. doi:10.1073/pnas.2003621117.
Chen, Xinhai, Shi, Miaomiao, Tong, Xin, Kim, Hwan Keun, Wang, Lai-Xi, Schneewind, Olaf, & Missiakas, Dominique. Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies. United States. https://doi.org/10.1073/pnas.2003621117
Chen, Xinhai, Shi, Miaomiao, Tong, Xin, Kim, Hwan Keun, Wang, Lai-Xi, Schneewind, Olaf, and Missiakas, Dominique. Thu . "Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies". United States. https://doi.org/10.1073/pnas.2003621117. https://www.osti.gov/servlets/purl/1815835.
@article{osti_1815835,
title = {Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies},
author = {Chen, Xinhai and Shi, Miaomiao and Tong, Xin and Kim, Hwan Keun and Wang, Lai-Xi and Schneewind, Olaf and Missiakas, Dominique},
abstractNote = {Antibodies may bind to bacterial pathogens or their toxins to control infections, and their effector activity is mediated through the recruitment of complement component C1q or the engagement with Fcγ receptors (FcγRs). For bacterial pathogens that rely on a single toxin to cause disease, immunity correlates with toxin neutralization. Most other bacterial pathogens, includingStaphylococcus aureus, secrete numerous toxins and evolved multiple mechanisms to escape opsonization and complement killing. Several vaccine candidates targeting defined surface antigens ofS. aureushave failed to meet clinical endpoints. It is unclear that such failures can be solely attributed to the poor selection of antibody targets. Thus far, studies to delineate antibody-mediated uptake and killing of Gram-positive pathogens remain extremely limited. Here, we exploit 3F6-hIgG1, a human monoclonal antibody that binds and neutralizes the abundant surface-exposed Staphylococcal protein A (SpA). We find that galactosylation of 3F6-hIgG1 that favors C1q recruitment is indispensable for opsonophagocytic killing of staphylococci and for protection against bloodstream infection in animals. However, the simple removal of fucosyl residues, which results in reduced C1q binding and increased engagement with FcγR, maintains the opsonophagocytic killing and protective attributes of the antibody. We confirm these results by engineering 3F6-hIgG1 variants with biased binding toward C1q or FcγRs. While the therapeutic benefit of monoclonal antibodies against infectious disease agents may be debatable, the functional characterization of such antibodies represents a powerful tool for the development of correlates of protection that may guide future vaccine trials.},
doi = {10.1073/pnas.2003621117},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
number = 37,
volume = 117,
place = {United States},
year = {Thu Aug 27 00:00:00 EDT 2020},
month = {Thu Aug 27 00:00:00 EDT 2020}
}

Works referenced in this record:

C5a anaphylatoxin is a major regulator of activating versus inhibitory FcγRs in immune complex–induced lung disease
journal, December 2002

  • Shushakova, Nelli; Skokowa, Julia; Schulman, Jurriaan
  • Journal of Clinical Investigation, Vol. 110, Issue 12
  • DOI: 10.1172/JCI200216577

Vaccines: Correlates of Vaccine‐Induced Immunity
journal, August 2008

  • Plotkin, Stanley A.
  • Clinical Infectious Diseases, Vol. 47, Issue 3
  • DOI: 10.1086/589862

Staphylococcal manipulation of host immune responses
journal, August 2015

  • Thammavongsa, Vilasack; Kim, Hwan Keun; Missiakas, Dominique
  • Nature Reviews Microbiology, Vol. 13, Issue 9
  • DOI: 10.1038/nrmicro3521

Both FcγRIV and FcγRIII are essential receptors mediating type II and type III autoimmune responses via FcRγ-LAT-dependent generation of C5a: Cellular immune response
journal, September 2009

  • Syed, Shahzad N.; Konrad, Stephanie; Wiege, Kristina
  • European Journal of Immunology, Vol. 39, Issue 12
  • DOI: 10.1002/eji.200939884

Building better monoclonal antibody-based therapeutics
journal, May 2015

  • Weiner, George J.
  • Nature Reviews Cancer, Vol. 15, Issue 6
  • DOI: 10.1038/nrc3930

Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus
journal, January 2015


Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
journal, May 2015

  • Tong, Steven Y. C.; Davis, Joshua S.; Eichenberger, Emily
  • Clinical Microbiology Reviews, Vol. 28, Issue 3
  • DOI: 10.1128/CMR.00134-14

Role of Protein A in the Evasion of Host Adaptive Immune Responses by Staphylococcus aureus
journal, August 2013

  • Falugi, Fabiana; Kim, Hwan Keun; Missiakas, Dominique M.
  • mBio, Vol. 4, Issue 5
  • DOI: 10.1128/mBio.00575-13

Peptidoglycan-linked protein A promotes T cell-dependent antibody expansion during Staphylococcus aureus infection
journal, May 2016

  • Kim, Hwan Keun; Falugi, Fabiana; Missiakas, Dominique M.
  • Proceedings of the National Academy of Sciences, Vol. 113, Issue 20
  • DOI: 10.1073/pnas.1524267113

Staphylococcus aureus infection induces protein A–mediated immune evasion in humans
journal, October 2014

  • Pauli, Noel T.; Kim, Hwan Keun; Falugi, Fabiana
  • Journal of Experimental Medicine, Vol. 211, Issue 12
  • DOI: 10.1084/jem.20141404

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose
journal, July 2011

  • Ferrara, C.; Grau, S.; Jager, C.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 31
  • DOI: 10.1073/pnas.1108455108

Staphylococcus aureus vaccines: Deviating from the carol
journal, August 2016

  • Missiakas, Dominique; Schneewind, Olaf
  • Journal of Experimental Medicine, Vol. 213, Issue 9
  • DOI: 10.1084/jem.20160569

The Role of the Complement System in Innate Immunity
journal, January 2005

  • Rus, Horea; Cudrici, Cornelia; Niculescu, Florin
  • Immunologic Research, Vol. 33, Issue 2
  • DOI: 10.1385/IR:33:2:103

Immunology's Coming of Age
journal, April 2019


Staphylococcus aureus expresses a cell surface protein that binds both IgG and β2-glycoprotein I
journal, January 1999


Prevalence of Staphylococcus aureus Nasal Colonization in the United States, 2001–2002
journal, January 2006

  • Kuehnert, Matthew J.; Kruszon‐Moran, Deanna; Hill, Holly A.
  • The Journal of Infectious Diseases, Vol. 193, Issue 2
  • DOI: 10.1086/499632

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
journal, August 2006


Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans
journal, July 2012


Pathogenesis of Staphylococcus aureus Bloodstream Infections
journal, May 2016


Nasal Carriage as a Source of Staphylococcus aureus Bacteremia
journal, January 2001

  • von Eiff, Christof; Becker, Karsten; Machka, Konstanze
  • New England Journal of Medicine, Vol. 344, Issue 1
  • DOI: 10.1056/NEJM200101043440102

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
journal, February 2016

  • van de Donk, Niels W. C. J.; Janmaat, Maarten L.; Mutis, Tuna
  • Immunological Reviews, Vol. 270, Issue 1
  • DOI: 10.1111/imr.12389

PROTEIN A FROM STAPHYLOCOCCUS AUREUS: THE BIOLOGICAL SIGNIFICANCE OF ITS REACTION WITH IgG
journal, July 1974


Complement: a key system for immune surveillance and homeostasis
journal, August 2010

  • Ricklin, Daniel; Hajishengallis, George; Yang, Kun
  • Nature Immunology, Vol. 11, Issue 9
  • DOI: 10.1038/ni.1923

Recurrent infections and immune evasion strategies of Staphylococcus aureus
journal, February 2012

  • Kim, Hwan Keun; Thammavongsa, Vilasack; Schneewind, Olaf
  • Current Opinion in Microbiology, Vol. 15, Issue 1
  • DOI: 10.1016/j.mib.2011.10.012

FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
journal, July 2005


Glycosylation as a strategy to improve antibody-based therapeutics
journal, March 2009

  • Jefferis, Roy
  • Nature Reviews Drug Discovery, Vol. 8, Issue 3
  • DOI: 10.1038/nrd2804

Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
journal, October 2015

  • Quast, Isaak; Keller, Christian W.; Maurer, Michael A.
  • Journal of Clinical Investigation, Vol. 125, Issue 11
  • DOI: 10.1172/JCI82695

Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions
journal, July 2012

  • Huang, Wei; Giddens, John; Fan, Shu-Quan
  • Journal of the American Chemical Society, Vol. 134, Issue 29
  • DOI: 10.1021/ja3051266

Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
journal, March 2014


Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
journal, August 2017


Staphylococcal Protein A and Human IgG Subclasses and Allotypes
journal, March 1982


A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses
journal, June 2017

  • Daum, Robert S.; Miller, Loren G.; Immergluck, Lilly
  • New England Journal of Medicine, Vol. 376, Issue 26
  • DOI: 10.1056/NEJMoa1607033

Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus
journal, January 2009


Transient Mammalian Cell Transfection with Polyethylenimine (PEI)
book, January 2013


Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice
journal, August 2010

  • Kim, Hwan Keun; Cheng, Alice G.; Kim, Hye-Young
  • The Journal of Experimental Medicine, Vol. 207, Issue 9
  • DOI: 10.1084/jem.20092514

Beyond binding: antibody effector functions in infectious diseases
journal, October 2017

  • Lu, Lenette L.; Suscovich, Todd J.; Fortune, Sarah M.
  • Nature Reviews Immunology, Vol. 18, Issue 1
  • DOI: 10.1038/nri.2017.106

Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies
journal, April 2010

  • Malphettes, Laetitia; Freyvert, Yevgeniy; Chang, Jennifer
  • Biotechnology and Bioengineering, Vol. 106, Issue 5
  • DOI: 10.1002/bit.22751

Chemical and Chemoenzymatic Synthesis of Glycoproteins for Deciphering Functions
journal, January 2014


Effector Function Activities of a Panel of Mutants of a Broadly Neutralizing Antibody against Human Immunodeficiency Virus Type 1
journal, December 2001


Complement and its role in innate and adaptive immune responses
journal, December 2009

  • Dunkelberger, Jason R.; Song, Wen-Chao
  • Cell Research, Vol. 20, Issue 1
  • DOI: 10.1038/cr.2009.139

The choice of mammalian cell host and possibilities for glycosylation engineering
journal, December 2014


Lymphocyte stimulation by protein A ofStaphylococcus aureus
journal, March 1976

  • Forsgren, A.; Svedjelund, A.; Wigzell, H.
  • European Journal of Immunology, Vol. 6, Issue 3
  • DOI: 10.1002/eji.1830060312

The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor
journal, August 2016


Fc receptor but not complement binding is important in antibody protection against HIV
journal, September 2007

  • Hessell, Ann J.; Hangartner, Lars; Hunter, Meredith
  • Nature, Vol. 449, Issue 7158
  • DOI: 10.1038/nature06106

Protein A-Specific Monoclonal Antibodies and Prevention of Staphylococcus aureus Disease in Mice
journal, July 2012

  • Kim, Hwan Keun; Emolo, Carla; DeDent, Andrea C.
  • Infection and Immunity, Vol. 80, Issue 10
  • DOI: 10.1128/IAI.00230-12

Staphylococcus aureus Decolonization of Mice With Monoclonal Antibody Neutralizing Protein A
journal, December 2018

  • Chen, Xinhai; Sun, Yan; Missiakas, Dominique
  • The Journal of Infectious Diseases, Vol. 219, Issue 6
  • DOI: 10.1093/infdis/jiy597

Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function
journal, January 2007

  • Zhou, Qun; Shankara, Srinivas; Roy, Andre
  • Biotechnology and Bioengineering, Vol. 99, Issue 3
  • DOI: 10.1002/bit.21598

Antibodies to watch in 2019
journal, December 2018


Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications
journal, January 2018

  • Heesterbeek, Dani A. C.; Angelier, Mathieu L.; Harrison, Richard A.
  • Journal of Innate Immunity, Vol. 10, Issue 5-6
  • DOI: 10.1159/000491439

Protein A Suppresses Immune Responses during Staphylococcus aureus Bloodstream Infection in Guinea Pigs
journal, February 2015


Emerging Technologies for Making Glycan-Defined Glycoproteins
journal, December 2011

  • Wang, Lai-Xi; Lomino, Joseph V.
  • ACS Chemical Biology, Vol. 7, Issue 1
  • DOI: 10.1021/cb200429n